Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surgical biology for the clinician: vascular effects of immunosuppression.

Literature DB >> 20100415

Surgical biology for the clinician: vascular effects of immunosuppression.

Elissa Tepperman¹, Danny Ramzy, Jessica Prodger, Rohit Sheshgiri, Mitesh Badiwala, Heather Ross, Vivek Raoa.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20100415 PMCID： PMC2810018

Source DB: PubMed Journal: Can J Surg ISSN： 0008-428X Impact factor: 2.089

× No keyword cloud information.

69 in total

1. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?

Authors: J Groetzner; B M Meiser; J Schirmer; J Koglin; W vScheidt; V Klauss; P Cremer; H Reichenspurner; B Reichart
Journal: Transplant Proc Date: 2001 Feb-Mar Impact factor: 1.066

Review 2. The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies.

Authors: B D Kahan
Journal: Transplant Proc Date: 2002-02 Impact factor: 1.066

3. Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.

Authors: Hugues Jeanmart; Olivier Malo; Michel Carrier; Caroline Nickner; Nathalie Desjardins; Louis P Perrault
Journal: J Heart Lung Transplant Date: 2002-09 Impact factor: 10.247

4. Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.

Authors: D A Baran; J Ashkar; I D Galin; D Sandler; L Segura; M C Courtney; R Correa; M Chan; S L Lansman; D Spielvogel; J Cheng; A L Gass
Journal: Transplant Proc Date: 2002-08 Impact factor: 1.066

5. Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation.

Authors: Y C Schrama; T van Dam; R Fijnheer; R J Hené; P de Groot; T J Rabelink
Journal: Neth J Med Date: 2001-07 Impact factor: 1.422

Review 6. Sirolimus: a comprehensive review.

Authors: B D Kahan
Journal: Expert Opin Pharmacother Date: 2001-11 Impact factor: 3.889

7. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients.

Authors: C A Ovuworie; E R Fox; C M Chow; M Pascual; V E Shih; M H Picard; N E Tolkoff-Rubin
Journal: Transplantation Date: 2001-10-27 Impact factor: 4.939

8. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.

Authors: S M Hollenberg; L W Klein; J E Parrillo; M Scherer; D Burns; P Tamburro; M Oberoi; M R Johnson; M R Costanzo
Journal: Circulation Date: 2001-12-18 Impact factor: 29.690

9. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.

Authors: S T Morris; J J McMurray; R S Rodger; R Farmer; A G Jardine
Journal: Kidney Int Date: 2000-03 Impact factor: 10.612

10. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study.

Authors: H Valantine; P Rickenbacker; M Kemna; S Hunt; Y D Chen; G Reaven; E B Stinson
Journal: Circulation Date: 2001-05-01 Impact factor: 29.690

11 in total

1. Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Authors: X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls
Journal: Am J Transplant Date: 2015-02-27 Impact factor: 8.086

Review 2. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors: Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal: Expert Opin Drug Metab Toxicol Date: 2011-02 Impact factor: 4.481

3. Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.

Authors: Ainhoa Fernández-Yunquera; Cristina Ripoll; Rafael Bañares; Marta Puerto; Diego Rincón; Ismael Yepes; Vega Catalina; Magdalena Salcedo
Journal: World J Transplant Date: 2014-06-24

4. The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.

Authors: Hongtao Hu; Shen Xu; Shuang Hu; Weijia Xu; Hua Shui
Journal: Exp Ther Med Date: 2017-06-08 Impact factor: 2.447

5. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells.

Authors: Damelys Calderon; Valérie Planat-Benard; Valérie Bellamy; Valérie Vanneaux; Chantal Kuhn; Severine Peyrard; Jérôme Larghero; Michel Desnos; Louis Casteilla; Michel Pucéat; Philippe Menasché; Lucienne Chatenoud
Journal: J Cell Mol Med Date: 2012-07 Impact factor: 5.310

6. Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats.

Authors: Katrin Splith; Peter Fellmer; Ivan Matia; Martin Varga; Martin Oliverius; Stephanie Kuhn; Linda Feldbrügge; Felix Krenzien; Hans-Michael Hau; Georg Wiltberger; Moritz Schmelzle; Sven Jonas
Journal: PLoS One Date: 2014-03-11 Impact factor: 3.240